Clinical Trial Update: Clinico-immunological Characterization and Immune Tolerance Breakdown in CV2-autoimmunity

View source ↗

Summary

The clinical trial NCT06620913 investigating clinico-immunological characterization and immune tolerance breakdown in CV2-autoimmunity is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cv2 Autoimmunity

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: CV2 Autoimmunity | Status: ACTIVE_NOT_RECRUITING